Michael Patrone is a partner in the firm’s Public M&A/Corporate Governance practice, Special Purpose Acquisition Companies (“SPAC”) practice and Life Sciences practice. Mr. Patrone’s practice focuses on all aspects of mergers and acquisitions, including representing both domestic and foreign entities, boards of directors, special board committees, private equity sponsors and investment banks in public and private company transactions, tender offers, joint ventures, transactions with SPACs, cross-border transactions, minority investments, shareholder activism and governance disputes, financial advisory matters and general corporate matters. Mr. Patrone represents a wide range of clients from a number of industries, including life sciences, biotech, pharmaceuticals, regenerative medicine, technology, software, healthcare, financial services and telecommunications.

Mr. Patrone joined the firm as a partner in 2018. He previously practiced in the M&A groups of each of Gibson, Dunn & Crutcher LLP and Davis Polk & Wardwell LLP in New York.





A selection of Mr. Patrone’s recent representations include:

Representative Matters



Mergers & Acquisitions
  • MyoKardia, Inc. in connection with its $13.1 billion sale to Bristol-Myers Squibb Company
  • Twilio Inc. in connection with its acquisition of SendGrid, Inc. in an all-stock transaction valued at approximately $3 billion
  • Investors in Signal Sciences Corp. in connection with Signal Sciences’ $775 million sale to Fastly, Inc.
  • Foundation Medicine, Inc. in connection with its merger with Roche at an enterprise valuation of $5.3 billion
  • PTC Inc. in connection with its strategic partnership with Rockwell Automation, Inc. and securing a $1 billion equity investment
  • Evergreen Coast Capital in connection with its $1.6 billion acquisition of Gigamon Inc.*
  • Hewlett Packard Enterprise Company in connection with the $7 billion spin-off and merger of its Enterprise Services business with Computer Sciences Corporation to form DXC Technology Company*
  • Hologic, Inc. in connection with the sale of its blood screening business for $1.85 billion to Grifols S.A.*
  • Diamond Resorts International, Inc. in connection with its $2.2 billion sale to Apollo Management*
  • Marriott International, Inc. in its $12.2 billion acquisition of Starwood Hotels & Resorts Worldwide, Inc.*
  • Shire plc in connection with its abandoned $54.8 billion sale to AbbVie Inc.*
  • Bertelsmann SE & Co. KGaA and Random House in connection with the merger of Random House with Penguin Publishing House*
  • Dalian Wanda Group in connection with its $2.6 billion acquisition of AMC Entertainment Holdings, Inc.*

*Denotes experience prior to joining Goodwin.

SPAC Transactions
  • Markforged, Inc. in connection with its pending business combination with SPAC one in a transaction valued at approximately $2.1 billion
  • Alpha Healthcare Acquisition Corp. in connection with its pending business combination with Humacyte, Inc. in a transaction valued at approximately $1.1 billion
  • Cano Health, LLC in connection with its business combination with SPAC Jaws Acquisition Corp in a transaction valued at approximately $5.9 billion  
  • Existing investors in Billtrust in connection with Billtrust’s business combination with SPAC South Mountain Merger Corporation in a transaction valued at approximately $2.5 billion
  • Immatics N.V. in connection with its business combination with SPAC Arya Sciences Acquisition Corp. in a transaction valued at approximately $1 billion


During law school, Mr. Patrone served on the executive boards of the Harvard Business Law Review and the Harvard Journal of Law & Public Policy. 

Mr. Patrone was recognized in the Financial Times Innovative Lawyers 2019: Enabling Business Growth and Transformation deal awards.

In The News









Harvard Law School
(cum laude)
M.S., Accounting
University of Florida

(Beta Alpha Psi)

B.S., Accounting
University of Florida



New York
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique